首页 > 最新文献

Critical Pathways in Cardiology最新文献

英文 中文
Is Intravascular Ultrasound-Guided Angiography a Better Choice Than Angiography Alone for Patients With Acute Coronary Syndrome and Coronary Artery Disease? Unveiling the Efficacy and Safety of This Modern Imaging Method: A Systematic Review and Meta-Analysis. 对于急性冠状动脉综合征和冠状动脉疾病患者,超声引导下血管造影比单独血管造影更好吗?揭示这种现代成像方法的有效性和安全性:一项系统回顾和荟萃分析。
Q3 Medicine Pub Date : 2025-09-01 Epub Date: 2025-05-12 DOI: 10.1097/HPC.0000000000000383
Khaled M Harmouch, Mobeen Haider, Mohammad Hamza, Prakash Upreti, Yasemin Bahar, Mustafa Turkmani, Tea Rrapo, Nomesh Kumar, Manoj Kumar, Wasif Safdar, Yasar Sattar, Fnu Zafrullah, Abu Mhafouz, M Chadi Alraies

Introduction: Coronary angiography has been an established standard for over 6 decades for percutaneous coronary interventions (PCIs), but its role is limited to assessing vascular lumen and anterograde flow. In the 1980s, intravascular ultrasonography (IVUS) gained traction in interventional cardiology for its advantages over angiography. Despite its precise evaluation of plaque burden and vessel wall structure for optimizing stent implantation, the literature reports varying outcomes on the efficacy and safety of IVUS-guided angiography in patients presenting with acute coronary syndrome or coronary artery disease. To address this discrepancy, we conducted a comprehensive systematic review and meta-analysis to assess the efficacy and safety of utilizing IVUS versus angiography alone for PCI in these groups of patients.

Methods: We conducted a comprehensive systematic review and meta-analysis to assess the efficacy and safety of IVUS-guided angiography in these patients. Electronic databases were searched, and 25 studies were included. Inclusion criteria are given as follows: (1) patients aged >18 years, (2) patients with acute coronary syndrome or coronary artery disease undergoing IVUS-guided PCI or angiography-guided PCI, and (3) randomized controlled trials. Exclusion criteria comprised observational, nonrandomized studies, case reports, clinical spotlights, and review articles. Studied outcomes included all-cause mortality, cardiac death, myocardial infarction, target lesion revascularization (TLR), need for coronary artery bypass graft, and stent thrombosis (ST).

Results: Compared with angiography alone, IVUS-guided PCI demonstrated a significant reduction in cardiac death, TLR, and ST regardless of the follow-up period. No significant difference was observed between the 2 groups concerning all-cause mortality, and myocardial infarction regardless of the follow-up period, and the need for coronary artery bypass graft at 1-year follow-up.

Conclusions: Compared with angiography-guided PCI, IVUS-guided PCI is associated with a lower incidence of cardiac death, TLR, and ST.

60多年来,冠状动脉造影一直是经皮冠状动脉介入治疗(PCI)的既定标准,但其作用仅限于评估血管腔和顺行血流。在20世纪80年代,血管内超声检查(IVUS)因其优于血管造影的优点而在介入心脏病学中受到关注。尽管可以精确评估斑块负担和血管壁结构以优化支架植入,但文献报道了ivus引导下的血管造影在急性冠脉综合征(ACS)或冠状动脉疾病(CAD)患者中的疗效和安全性的不同结果。为了解决这一差异,我们进行了一项全面的系统回顾和荟萃分析,以评估在这些患者中使用IVUS与单独血管造影进行PCI的有效性和安全性。方法:我们进行了一项全面的系统回顾和荟萃分析,以评估ivus引导的血管造影在这些患者中的有效性和安全性。检索了电子数据库,纳入了25项研究。纳入标准为:1)年龄在bb0 ~ 18岁的患者,2)ACS或CAD患者接受ivus引导的PCI或血管造影引导的PCI, 3)随机临床试验(RCTs)。排除标准包括观察性、非随机研究、病例报告、临床重点报道和综述文章。研究结果包括全因死亡率、心源性死亡、心肌梗死(MI)、靶病变血运重建术(TLR)、冠状动脉旁路移植术(CABG)和支架血栓形成(ST)。结果:与单独的血管造影相比,无论随访时间如何,ivus引导下的PCI均能显著降低心脏死亡、TLR和ST。无论随访时间如何,两组在全因死亡率和心肌梗死以及一年随访时是否需要冠脉搭桥方面均无显著差异。结论:与血管造影引导下的PCI相比,ivus引导下的PCI与心脏死亡、TLR和ST的发生率较低相关。
{"title":"Is Intravascular Ultrasound-Guided Angiography a Better Choice Than Angiography Alone for Patients With Acute Coronary Syndrome and Coronary Artery Disease? Unveiling the Efficacy and Safety of This Modern Imaging Method: A Systematic Review and Meta-Analysis.","authors":"Khaled M Harmouch, Mobeen Haider, Mohammad Hamza, Prakash Upreti, Yasemin Bahar, Mustafa Turkmani, Tea Rrapo, Nomesh Kumar, Manoj Kumar, Wasif Safdar, Yasar Sattar, Fnu Zafrullah, Abu Mhafouz, M Chadi Alraies","doi":"10.1097/HPC.0000000000000383","DOIUrl":"10.1097/HPC.0000000000000383","url":null,"abstract":"<p><strong>Introduction: </strong>Coronary angiography has been an established standard for over 6 decades for percutaneous coronary interventions (PCIs), but its role is limited to assessing vascular lumen and anterograde flow. In the 1980s, intravascular ultrasonography (IVUS) gained traction in interventional cardiology for its advantages over angiography. Despite its precise evaluation of plaque burden and vessel wall structure for optimizing stent implantation, the literature reports varying outcomes on the efficacy and safety of IVUS-guided angiography in patients presenting with acute coronary syndrome or coronary artery disease. To address this discrepancy, we conducted a comprehensive systematic review and meta-analysis to assess the efficacy and safety of utilizing IVUS versus angiography alone for PCI in these groups of patients.</p><p><strong>Methods: </strong>We conducted a comprehensive systematic review and meta-analysis to assess the efficacy and safety of IVUS-guided angiography in these patients. Electronic databases were searched, and 25 studies were included. Inclusion criteria are given as follows: (1) patients aged >18 years, (2) patients with acute coronary syndrome or coronary artery disease undergoing IVUS-guided PCI or angiography-guided PCI, and (3) randomized controlled trials. Exclusion criteria comprised observational, nonrandomized studies, case reports, clinical spotlights, and review articles. Studied outcomes included all-cause mortality, cardiac death, myocardial infarction, target lesion revascularization (TLR), need for coronary artery bypass graft, and stent thrombosis (ST).</p><p><strong>Results: </strong>Compared with angiography alone, IVUS-guided PCI demonstrated a significant reduction in cardiac death, TLR, and ST regardless of the follow-up period. No significant difference was observed between the 2 groups concerning all-cause mortality, and myocardial infarction regardless of the follow-up period, and the need for coronary artery bypass graft at 1-year follow-up.</p><p><strong>Conclusions: </strong>Compared with angiography-guided PCI, IVUS-guided PCI is associated with a lower incidence of cardiac death, TLR, and ST.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0383"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The QRS Interval After Pacemaker Implant: An Independent Mortality Risk Factor. 心脏起搏器植入后QRS间期:一个独立的死亡危险因素?
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000385
Gabriel Vanerio

Background: We have been pacing the right ventricular apex, creating an artificial left bundle branch block (LBBB) for more than 4 decades. We learned that some patients would develop dys-synchronization and hence heart failure due to QRS widening. If the lead is implanted in the left bundle area and a narrow QRS is achieved, those patients with LBBB will improve after implant, but those with non-LBBB morphologies might not benefit from QRS narrowing. However, there is not enough information regarding patients with narrow or wide QRS with different types of atrioventricular block that could also benefit from QRS narrowing.

Objectives: Demonstrate that a narrow-paced QRS is a significant determinant of mortality in patients receiving a permanent pacemaker despite the previous QRS morphology.

Patients and methods: We analyzed 204 patients from our pacemaker database. We attempted to implant the lead in the septal area. In our lab, we utilized standard lead electrodes. The criteria for appropriate implant were an electrogram with injury potential, an acceptable lead positioning in the right anterior oblique and left anterior oblique, and a ventricular bipolar threshold less or equal to 1.0 V @ 0.5 ms. QRS duration was assessed according to the global QRS method (from the earliest onset of the QRS in any of the 12 simultaneously recorded standard leads). A QRS interval of 135 ms was determined as a cutoff point using a receiver operator curve (mortality).

Results: The first implants were performed in March 2008 and ended in March 2024. A narrow QRS (<135 ms) was observed in 140 subjects (140/204, 68%). The primary endpoint (death from cardiovascular cause) was met in 10 (4.9%) patients. LBBB was present before implant in 29 patients and a QRS <135 ms was measured in 12/29 (41%). We did not observe more complications compared with the conventional technique. The survival curve using Kaplan-Meier analysis comparing the 2 groups was significantly different with a significant mortality reduction in the narrow QRS group.

Conclusions: A narrow-paced QRS is an independent variable associated with increased survival rates.

背景:40多年来,我们一直在对右心室尖部进行起搏,制造人工左束支阻滞(LBBB)。我们了解到,由于QRS增宽,一些患者会出现同步化异常,从而导致心力衰竭。如果导联植入左束区,QRS变窄,LBBB患者在植入后会得到改善,而非LBBB形态的患者可能不会从QRS变窄中获益。然而,关于QRS狭窄或宽且不同类型房室传导阻滞的患者是否也能从QRS狭窄中获益的信息还不够。目的:证明窄幅QRS是接受永久性起搏器的患者死亡率的重要决定因素,尽管以前的QRS形态。患者和方法:我们分析了来自起搏器数据库的204例患者。我们试图在间隔区植入导线。在我们的实验室里,我们使用了标准的铅电极。合适植入的标准是有损伤电位的心电图,可接受的右前斜和左前斜导联定位,以及心室双极阈值小于或等于1.0 V @ 0.5 ms。QRS持续时间根据全局QRS方法进行评估(从12个同时记录的标准导联中任何一个QRS最早开始)。QRS时间间隔为135 ms,采用接收者操作符曲线(死亡率)作为截断点。结果:首次种植于2008年3月完成,2024年3月结束。狭窄的QRS(结论:狭窄的QRS是与生存率增加相关的独立变量。
{"title":"The QRS Interval After Pacemaker Implant: An Independent Mortality Risk Factor.","authors":"Gabriel Vanerio","doi":"10.1097/HPC.0000000000000385","DOIUrl":"10.1097/HPC.0000000000000385","url":null,"abstract":"<p><strong>Background: </strong>We have been pacing the right ventricular apex, creating an artificial left bundle branch block (LBBB) for more than 4 decades. We learned that some patients would develop dys-synchronization and hence heart failure due to QRS widening. If the lead is implanted in the left bundle area and a narrow QRS is achieved, those patients with LBBB will improve after implant, but those with non-LBBB morphologies might not benefit from QRS narrowing. However, there is not enough information regarding patients with narrow or wide QRS with different types of atrioventricular block that could also benefit from QRS narrowing.</p><p><strong>Objectives: </strong>Demonstrate that a narrow-paced QRS is a significant determinant of mortality in patients receiving a permanent pacemaker despite the previous QRS morphology.</p><p><strong>Patients and methods: </strong>We analyzed 204 patients from our pacemaker database. We attempted to implant the lead in the septal area. In our lab, we utilized standard lead electrodes. The criteria for appropriate implant were an electrogram with injury potential, an acceptable lead positioning in the right anterior oblique and left anterior oblique, and a ventricular bipolar threshold less or equal to 1.0 V @ 0.5 ms. QRS duration was assessed according to the global QRS method (from the earliest onset of the QRS in any of the 12 simultaneously recorded standard leads). A QRS interval of 135 ms was determined as a cutoff point using a receiver operator curve (mortality).</p><p><strong>Results: </strong>The first implants were performed in March 2008 and ended in March 2024. A narrow QRS (<135 ms) was observed in 140 subjects (140/204, 68%). The primary endpoint (death from cardiovascular cause) was met in 10 (4.9%) patients. LBBB was present before implant in 29 patients and a QRS <135 ms was measured in 12/29 (41%). We did not observe more complications compared with the conventional technique. The survival curve using Kaplan-Meier analysis comparing the 2 groups was significantly different with a significant mortality reduction in the narrow QRS group.</p><p><strong>Conclusions: </strong>A narrow-paced QRS is an independent variable associated with increased survival rates.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0385"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management and Outcomes of Coronary Artery Aneurysms: A Patient-Level Systematic Review. 冠状动脉瘤的治疗和预后:一项患者水平的系统综述。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000381
Daler Rahimov, Nayeem Nasher, Danial Ahmad, Rohinton J Morris, Anjali Upadhyaya, Colin Yost, Daniella Wong, Preeyal Patel, Alec Vishnevsky, Nicholas J Ruggiero, John W Entwistle, Vakhtang Tchantchaleishvili

Background: Data are lacking to guide standardized management of coronary artery aneurysms (CAAs). We sought to analyze the available evidence in a quantitative manner.

Methods: An electronic search identified 431 case reports or case series on CAA, comprising 488 patients. Patient-level data were extracted. Subgroups of CAA with fistulous connections (CAAF) and CAA without fistulous connections (CAAO) were analyzed separately.

Results: Fistulous connection was present in 24.0% (117/488) of patients with CAA. Angina was a presenting symptom in 64.7% (301/465), with higher preponderance in the CAAO group [CAAO: 71.1% (249/350) versus CAAF: 45.2% (52/115); P < 0.01]. The median largest aneurysm diameter was higher in the CAAF group [CAAO: 3.0 (1.5-5.0) cm versus CAAF: 5.0 (3.0-7.0) cm; P < 0.01], and rupture was more frequently observed in the CAAF group [CAAO: 3.1% (11/353) versus CAAF: 13.8% (16/116); P < 0.01]. For any given diameter, CAAF had a higher risk of rupture compared with CAAO. Surgery was the most common management strategy, particularly in patients with CAAF [CAAO: 50.9% (189/371) versus CAAF: 75.2% (88/117); P < 0.01]. The Kaplan-Meier analysis showed a trend toward more favorable survival in CAAF. The hazard of mortality was associated with aneurysm diameter in both subsets but was higher in the CAAO group independent of surgical versus interventional management.

Conclusions: CAAF appears to have a higher risk of rupture but may be associated with better survival than CAAO. Management for patients with CAA differs based on the presence or absence of a fistula; however, both surgical and interventional modes of management result in similar survival.

背景:缺乏指导冠状动脉瘤(CAA)规范化治疗的数据。我们试图以定量的方式分析现有的证据。方法:电子检索431例CAA病例报告或病例系列,包括488例患者。提取患者层面的数据。有(CAAF)和无(CAAO)亚组分别进行分析。结果:24.0%(117/488)的CAA患者存在瘘连接。64.7%(301/465)的患者以心绞痛为主要症状,CAAO组的发生率更高[CAAO组:71.1% (249/350)vs CAAF组:45.2%(52/115)]。结论:CAAF似乎有更高的破裂风险,但可能比CAAO有更好的生存。CAA患者的治疗方法因是否存在瘘而不同,然而,手术和介入治疗的生存率相似。
{"title":"Management and Outcomes of Coronary Artery Aneurysms: A Patient-Level Systematic Review.","authors":"Daler Rahimov, Nayeem Nasher, Danial Ahmad, Rohinton J Morris, Anjali Upadhyaya, Colin Yost, Daniella Wong, Preeyal Patel, Alec Vishnevsky, Nicholas J Ruggiero, John W Entwistle, Vakhtang Tchantchaleishvili","doi":"10.1097/HPC.0000000000000381","DOIUrl":"10.1097/HPC.0000000000000381","url":null,"abstract":"<p><strong>Background: </strong>Data are lacking to guide standardized management of coronary artery aneurysms (CAAs). We sought to analyze the available evidence in a quantitative manner.</p><p><strong>Methods: </strong>An electronic search identified 431 case reports or case series on CAA, comprising 488 patients. Patient-level data were extracted. Subgroups of CAA with fistulous connections (CAAF) and CAA without fistulous connections (CAAO) were analyzed separately.</p><p><strong>Results: </strong>Fistulous connection was present in 24.0% (117/488) of patients with CAA. Angina was a presenting symptom in 64.7% (301/465), with higher preponderance in the CAAO group [CAAO: 71.1% (249/350) versus CAAF: 45.2% (52/115); P < 0.01]. The median largest aneurysm diameter was higher in the CAAF group [CAAO: 3.0 (1.5-5.0) cm versus CAAF: 5.0 (3.0-7.0) cm; P < 0.01], and rupture was more frequently observed in the CAAF group [CAAO: 3.1% (11/353) versus CAAF: 13.8% (16/116); P < 0.01]. For any given diameter, CAAF had a higher risk of rupture compared with CAAO. Surgery was the most common management strategy, particularly in patients with CAAF [CAAO: 50.9% (189/371) versus CAAF: 75.2% (88/117); P < 0.01]. The Kaplan-Meier analysis showed a trend toward more favorable survival in CAAF. The hazard of mortality was associated with aneurysm diameter in both subsets but was higher in the CAAO group independent of surgical versus interventional management.</p><p><strong>Conclusions: </strong>CAAF appears to have a higher risk of rupture but may be associated with better survival than CAAO. Management for patients with CAA differs based on the presence or absence of a fistula; however, both surgical and interventional modes of management result in similar survival.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0381"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Embolic Protection in Percutaneous Coronary Intervention Without Saphenous Venous Graft Lesions in ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis: Erratum. st段抬高型心肌梗死经皮冠状动脉介入治疗无隐静脉移植物损害时栓塞保护的作用:一项系统回顾和荟萃分析:勘误。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000389
Maisha Maliha, Vikyath Satish, Kuan Yu Chi, Diego Barzallo Zeas, Amrin Kharawala, Nishat Shama, Nathaniel Abittan, Sneha Nandy, Anita Osabutey, Nidhi Madan, Prabhjot Singh, Eleonora Gashi
{"title":"Role of Embolic Protection in Percutaneous Coronary Intervention Without Saphenous Venous Graft Lesions in ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis: Erratum.","authors":"Maisha Maliha, Vikyath Satish, Kuan Yu Chi, Diego Barzallo Zeas, Amrin Kharawala, Nishat Shama, Nathaniel Abittan, Sneha Nandy, Anita Osabutey, Nidhi Madan, Prabhjot Singh, Eleonora Gashi","doi":"10.1097/HPC.0000000000000389","DOIUrl":"10.1097/HPC.0000000000000389","url":null,"abstract":"","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0376"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rewarding 20-Year Experience With Initial and Repeat EKG and Echocardiographic Screening for Prevention of Sudden Death in Detecting Abnormal Findings. 奖励二十年来在发现异常发现预防猝死方面进行初始和重复心电图和超声心动图筛查的经验。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000382
Sharon Bates, Mohammad Reza Movahed

Background: To further analyze the impacts, findings, and modalities of multiple cardiac screenings to answer the question, are multiple screens necessary and useful in youth?

Methods: Over 20 years, the Anthony Bates Foundation (ABF) has offered free and low-cost cardiac screenings to youth and their families nationwide. The volunteer force has provided blood pressure and ultrasound tests to participants throughout the 20 years. After year 7, electrocardiograms were added to the screening.

Results: Over the 20 years, ABF abnormal findings held steady between 10% and 13%, with potential life-threatening findings at 2.5%. The participants who have experienced multiple screening tests on average would repeat within 2.5 years and have abnormal findings at 31.84%, potential life-threatening at 11.43%, and total echocardiography-related abnormal findings at 16.82%. The variance between male and female attendance by age is also noted during the review of ABF repeat screened data. Male attendance was at 59.65% and female 40.35%. The abnormality rate of males for the first visit was 10.9% followed by the second visit of 18.80%. The abnormality rate of females for the first visit was 12.22% followed by the second visit of 17.09%. A detailed analysis of abnormal findings is presented in this article.

Conclusions: Cardiac screening involving multiple repeated screenings appears to be effective in detecting increasing numbers of abnormal findings that can be lifesaving.

背景:为了进一步分析多重心脏筛查的影响、发现和方式,以回答这个问题——多重筛查对年轻人是否必要和有用?方法:20多年来,安东尼贝茨基金会(ABF)在全国范围内为青少年及其家庭提供免费和低成本的心脏筛查。20年来,志愿者部队一直为参与者提供血压和超声波检查。第7年后,心电图也加入到筛查中。结果:20年来,ABF异常发现稳定在10 - 13%之间,潜在危及生命(PLT)的发现占2.5%。经历多次筛查的参与者平均在2.5年内重复,异常发现率为31.84%,PLT为11.43%,超声心动图相关的总异常发现率为16.82%。在对ABF重复筛选数据进行审查时,还注意到男性和女性按年龄出勤的差异。男性出席率为59.65%,女性为40.35%。男性首次访视异常率为10.9%,第二次访视异常率为18.80%。女性首次访视异常率为12.22%,第二次访视异常率为17.09%。本文对异常结果作了详细的分析。结论:心脏筛查涉及多次重复筛查似乎可以有效地发现越来越多的异常发现,从而挽救生命。
{"title":"Rewarding 20-Year Experience With Initial and Repeat EKG and Echocardiographic Screening for Prevention of Sudden Death in Detecting Abnormal Findings.","authors":"Sharon Bates, Mohammad Reza Movahed","doi":"10.1097/HPC.0000000000000382","DOIUrl":"10.1097/HPC.0000000000000382","url":null,"abstract":"<p><strong>Background: </strong>To further analyze the impacts, findings, and modalities of multiple cardiac screenings to answer the question, are multiple screens necessary and useful in youth?</p><p><strong>Methods: </strong>Over 20 years, the Anthony Bates Foundation (ABF) has offered free and low-cost cardiac screenings to youth and their families nationwide. The volunteer force has provided blood pressure and ultrasound tests to participants throughout the 20 years. After year 7, electrocardiograms were added to the screening.</p><p><strong>Results: </strong>Over the 20 years, ABF abnormal findings held steady between 10% and 13%, with potential life-threatening findings at 2.5%. The participants who have experienced multiple screening tests on average would repeat within 2.5 years and have abnormal findings at 31.84%, potential life-threatening at 11.43%, and total echocardiography-related abnormal findings at 16.82%. The variance between male and female attendance by age is also noted during the review of ABF repeat screened data. Male attendance was at 59.65% and female 40.35%. The abnormality rate of males for the first visit was 10.9% followed by the second visit of 18.80%. The abnormality rate of females for the first visit was 12.22% followed by the second visit of 17.09%. A detailed analysis of abnormal findings is presented in this article.</p><p><strong>Conclusions: </strong>Cardiac screening involving multiple repeated screenings appears to be effective in detecting increasing numbers of abnormal findings that can be lifesaving.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0382"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter Aortic Valve Implantation in Brazilian Public Health System: A Single-Center Experience. 经导管主动脉瓣植入在巴西公共卫生系统:单一中心的经验。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000387
Guilherme Pinheiro Machado, Pedro Castilhos Crivelaro, Gustavo Neves de Araujo, Alan Pagnoncelli, Julia Carvalho da Silva, Camila Porto Cardoso, Wagner Tadeu Azeredo Azevedo, Rodrigo Petersen Saadi, Eduardo Keller Saadi, Orlando Wender, Marco Wainstein, Felipe Costa Fuchs

Background: Transcatheter aortic valve implantation (TAVI) has been established as the treatment of choice for severe aortic stenosis in high-risk patients as well as patients above 75 years old in all risk spectrums. Despite its worldwide adoption, implementation in lower-middle-income countries such as the Brazilian public health system (SUS, acronym in Portuguese) is incipient.

Objectives: This study aimed to evaluate TAVI exclusively within SUS patients.

Methods: This was a prospective cohort study in a public tertiary hospital in southern Brazil. All patients who underwent TAVI between 2018 and 2024 were included. The cohort was divided into 2 temporal periods: from July 2018 to December 2022 (n = 60) and January 2023 to October 2024 (n = 65). The clinical and procedural characteristics and in-hospital, as well as 1 year of outcomes, were evaluated according to Valve Academic Research Consortium-2 (VARC-2) criteria.

Results: During the study period, 125 patients underwent TAVI. The average age was 80 years (± 10), and 49.6% were male. The mean aortic valve area was 0.76 cm² and the mean gradient was 45 (±13) mm Hg. The mean STS predicted risk of mortality (STS-PROM) score was 4.6% (±3.6). Device success was achieved in 119 patients (95.2%). In-hospital mortality was 2 (1.6%). A new permanent pacemaker was required in 16 (12.8%). Demographic and clinical characteristics between the first and the second periods were similar.

Conclusions: The mortality and complications rate of TAVI performed within the scope of the Brazilian public health system were consistent with the clinical experience of other international registries.

背景:经导管主动脉瓣植入术(TAVI)已被确定为治疗重度主动脉瓣狭窄的高危人群以及75岁以上所有危险谱患者的首选方法。尽管它在世界范围内被采用,但在巴西公共卫生系统(SUS,葡萄牙语首字母缩略词)等中低收入国家的实施才刚刚开始。目的:本研究旨在专门评估SUS患者的TAVI。方法:在巴西南部一家公立三级医院进行前瞻性队列研究。所有在2018年至2024年间接受TAVI的患者都被纳入其中。该队列被分为两个时间段:2018年7月至2022年12月(n=60)和2023年1月至2024年10月(n=65)。根据瓣膜学术研究联盟-2 (VARC-2)标准评估临床和手术特征、住院和1年预后。结果:在研究期间,125例患者接受了TAVI。平均年龄80岁(±10岁),男性占49.6%。平均主动脉瓣面积为0.76 cm2,平均梯度为45(±13)mmHg。STS预测死亡风险(STS- prom)平均评分为4.6%(±3.6)。119例患者(95.2%)器械成功。住院死亡率为2(1.6%)。16例(12.8%)需要新的永久性起搏器。第一期和第二期的人口学和临床特征相似。结论:在巴西公共卫生系统范围内进行TAVI的死亡率和并发症发生率与其他国际登记的临床经验一致。
{"title":"Transcatheter Aortic Valve Implantation in Brazilian Public Health System: A Single-Center Experience.","authors":"Guilherme Pinheiro Machado, Pedro Castilhos Crivelaro, Gustavo Neves de Araujo, Alan Pagnoncelli, Julia Carvalho da Silva, Camila Porto Cardoso, Wagner Tadeu Azeredo Azevedo, Rodrigo Petersen Saadi, Eduardo Keller Saadi, Orlando Wender, Marco Wainstein, Felipe Costa Fuchs","doi":"10.1097/HPC.0000000000000387","DOIUrl":"10.1097/HPC.0000000000000387","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve implantation (TAVI) has been established as the treatment of choice for severe aortic stenosis in high-risk patients as well as patients above 75 years old in all risk spectrums. Despite its worldwide adoption, implementation in lower-middle-income countries such as the Brazilian public health system (SUS, acronym in Portuguese) is incipient.</p><p><strong>Objectives: </strong>This study aimed to evaluate TAVI exclusively within SUS patients.</p><p><strong>Methods: </strong>This was a prospective cohort study in a public tertiary hospital in southern Brazil. All patients who underwent TAVI between 2018 and 2024 were included. The cohort was divided into 2 temporal periods: from July 2018 to December 2022 (n = 60) and January 2023 to October 2024 (n = 65). The clinical and procedural characteristics and in-hospital, as well as 1 year of outcomes, were evaluated according to Valve Academic Research Consortium-2 (VARC-2) criteria.</p><p><strong>Results: </strong>During the study period, 125 patients underwent TAVI. The average age was 80 years (± 10), and 49.6% were male. The mean aortic valve area was 0.76 cm² and the mean gradient was 45 (±13) mm Hg. The mean STS predicted risk of mortality (STS-PROM) score was 4.6% (±3.6). Device success was achieved in 119 patients (95.2%). In-hospital mortality was 2 (1.6%). A new permanent pacemaker was required in 16 (12.8%). Demographic and clinical characteristics between the first and the second periods were similar.</p><p><strong>Conclusions: </strong>The mortality and complications rate of TAVI performed within the scope of the Brazilian public health system were consistent with the clinical experience of other international registries.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0387"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Altered Anthropometrics and HbA1c Levels, but not Dyslipidemia, Are Associated With Elevated hs-CRP Levels in Middle-aged Adults: A Population-based Analysis. 人体测量学和 HA1c 水平的改变(而非血脂异常)与中年人 hs-CRP 水平的升高有关:基于人群的分析。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000378
Laith Ashour, Layan Ayesh, Zeid Jarrar, Areen Mishleb, Danah Alenezi, Moath Fateh, Rawan Almejaibal, Nicola Hanna Madani, Muath Mohammad Dabas, Sama Samer Abu Monshar, Samar Hamdan

Population-based studies of cardiovascular disease markers, such as high-sensitivity C-reactive protein (hs-CRP), are crucial. However, studies exploring the effect of metabolic indices on hs-CRP while controlling for confounding variables adequately in middle-aged adults are limited. Using Wave 5 public-use biomarkers data from the National Longitudinal Study of Adolescent to Adult Health (Add Health), we examined the impact of various metabolic indices on hs-CRP in adults aged 32-42, controlling for eight allergic and infectious factors that may elevate hs-CRP levels. We used multiple linear regression analysis to determine which factors predict hs-CRP levels after the log transformation of the dependent variable. The total number of participants was N = 1839 (weighted N = 1,390,763), with a mean age of 38.1 (SD = 2.0) and 46.4% having obesity. Among the controlled variables, recent surgery was the only confounder to significantly predict increased hs-CRP levels [ P = 0.029; exponentiated estimate (EE) = 1.61; 95% confidence interval (Cl), 1.31-1.91]. Notably, current smoking and altered low-density lipoprotein levels did not show a significant association with hs-CRP levels ( P > 0.05). However, a significant increase in hs-CRP levels was observed in females compared with males ( P < 0.001; EE = 1.43; 95% Cl, 1.35-1.51). Similar findings were noted for diabetic HbA1c levels ( P = 0.001; EE = 1.6; 95% CI, 1.42-1.78), high waist circumference ( P = 0.015; EE = 1.25; 95% CI, 1.15-1.35), and stage 3 obesity ( P = 0.006; EE = 7.62; 95% CI, 2.86-12.38). Although not statistically significant, hs-CRP levels exhibited a gradual increase with rising body mass index after controlling for other variables. These findings will improve the clinical application of hs-CRP in predicting coronary artery disease, especially in younger adults.

对心血管疾病标志物(如 hs-CRP)进行基于人群的研究至关重要。然而,在充分控制中年人混杂变量的情况下,探讨代谢指数对 hs-CRP 影响的研究非常有限。利用全国青少年健康纵向研究(Add Health)的第 5 波数据,我们研究了各种代谢指数对 32-42 岁成年人的 hs-CRP 的影响,同时控制了可能导致 hs-CRP 水平升高的八种过敏和感染因素。我们使用多元线性回归分析来确定哪些因素可以预测因变量对数变换后的 hs-CRP 水平。参与者总数为 N = 1839(加权 N = 1390763),平均年龄为 38.1 岁(SD = 2.0),46.4% 患有肥胖症。在控制变量中,近期手术是唯一能显著预测 hs-CRP 水平升高的混杂因素(P = 0.029,指数估计值 (EE) = 1.61;95% Cl:[1.31-1.91]).值得注意的是,目前吸烟和低密度脂蛋白或总胆固醇水平的改变与 hs-CRP 水平没有显著关联(P > 0.05)。然而,与男性相比,女性的 hs-CRP 水平明显升高(P < 0.001,EE = 1.43;95%Cl:[1.35-1.51])。糖尿病 HbA1c 水平(P = 0.001,EE = 1.6;95%CL:[1.42-1.78])、高腰围(P = 0.015,EE = 1.25;95%CL:[1.15-1.35])和 3 级肥胖(P = 0.006,EE = 7.62;95%CL:[2.86-12.38])也有类似发现。尽管没有统计学意义,但在控制了其他变量后,hs-CRP水平随着体重指数的升高而逐渐增加。这些发现将提高 hs-CRP 在预测冠状动脉疾病方面的临床应用,尤其是在年轻人中。
{"title":"Altered Anthropometrics and HbA1c Levels, but not Dyslipidemia, Are Associated With Elevated hs-CRP Levels in Middle-aged Adults: A Population-based Analysis.","authors":"Laith Ashour, Layan Ayesh, Zeid Jarrar, Areen Mishleb, Danah Alenezi, Moath Fateh, Rawan Almejaibal, Nicola Hanna Madani, Muath Mohammad Dabas, Sama Samer Abu Monshar, Samar Hamdan","doi":"10.1097/HPC.0000000000000378","DOIUrl":"10.1097/HPC.0000000000000378","url":null,"abstract":"<p><p>Population-based studies of cardiovascular disease markers, such as high-sensitivity C-reactive protein (hs-CRP), are crucial. However, studies exploring the effect of metabolic indices on hs-CRP while controlling for confounding variables adequately in middle-aged adults are limited. Using Wave 5 public-use biomarkers data from the National Longitudinal Study of Adolescent to Adult Health (Add Health), we examined the impact of various metabolic indices on hs-CRP in adults aged 32-42, controlling for eight allergic and infectious factors that may elevate hs-CRP levels. We used multiple linear regression analysis to determine which factors predict hs-CRP levels after the log transformation of the dependent variable. The total number of participants was N = 1839 (weighted N = 1,390,763), with a mean age of 38.1 (SD = 2.0) and 46.4% having obesity. Among the controlled variables, recent surgery was the only confounder to significantly predict increased hs-CRP levels [ P = 0.029; exponentiated estimate (EE) = 1.61; 95% confidence interval (Cl), 1.31-1.91]. Notably, current smoking and altered low-density lipoprotein levels did not show a significant association with hs-CRP levels ( P > 0.05). However, a significant increase in hs-CRP levels was observed in females compared with males ( P < 0.001; EE = 1.43; 95% Cl, 1.35-1.51). Similar findings were noted for diabetic HbA1c levels ( P = 0.001; EE = 1.6; 95% CI, 1.42-1.78), high waist circumference ( P = 0.015; EE = 1.25; 95% CI, 1.15-1.35), and stage 3 obesity ( P = 0.006; EE = 7.62; 95% CI, 2.86-12.38). Although not statistically significant, hs-CRP levels exhibited a gradual increase with rising body mass index after controlling for other variables. These findings will improve the clinical application of hs-CRP in predicting coronary artery disease, especially in younger adults.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0378"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of the Presence of Interatrial Block as a Prediction Pathway of Atrial Fibrillation During the Postoperative Period of Patients Undergoing Cardiac Surgery. 心房传导阻滞作为心脏手术患者术后房颤预测途径的作用
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000384
Alfredo J Meza-Delgado, Osmar Antonio Centurión, Christian O Chavez-Alfonso, Rocío Del Pilar Falcón-Fleytas, Laura B García-Bello, Orlando R Sequeira-Villar, Carmen R Montiel-Gómez, José C Candia-Irala, Erdulfo J Galeano

Background: Atrial fibrillation (AF) is the most frequently recorded arrhythmia in clinical practice, and its appearance conditions high risk of morbidity and mortality. The role of the interatrial block (IAB) as a predictor pathway of the development of AF in the postoperative period of patients undergoing cardiac surgery has been studied scantly.

Methods: Partial IAB was defined as the P wave >120 ms and advanced IAB as the P wave >120 ms with biphasic morphology in inferior leads. The presurgical electrocardiography was analyzed, and the frequency of AF onset in the postoperative period was determined. A comparative analysis was performed between the patients who presented AF and those who did not.

Results: A total of 94 patients were included, with a mean age of 61 ± 16 years. Of the total number of patients, 42 (45%) presented some degree of IAB (partial 42.8% and advanced 57.1%). There was a significant relationship between patients with IAB and those who developed AF postcardiac surgery (21.3%; P < 0.01). The presence of IAB had an area under the curve of 0.75 (95% confidence interval, 0.66-0.85) and demonstrated a specificity of 69%, a sensitivity of 83%, and a negative predictive value of 92% for predicting AF development.

Conclusions: IAB has a relatively frequent incidence in patients undergoing cardiac surgery. There was a significant association between the presence of IAB and the development of AF in the postoperative period. Our findings establish for the first time that IAB has high specificity, sensitivity, and negative predictive value for predicting AF development postcardiac surgery.

背景:心房颤动(AF)是临床上最常见的心律失常,其出现会导致高发病率和高死亡率。心房间阻滞(IAB)是心脏手术患者术后发生房颤的预测途径,但对其作用的研究却很少:部分IAB定义为P波>120毫秒,晚期IAB定义为P波>120毫秒且下导联呈双相形态。对手术前的心电图进行分析,并确定术后房颤发生的频率。对出现房颤和未出现房颤的患者进行了对比分析:共纳入 94 例患者,平均年龄为 61±16 岁。在所有患者中,42 人(45%)患有某种程度的 IAB(部分 42.8%,晚期 57.1%)。IAB患者与心脏手术后出现房颤的患者(21.3%)之间存在明显关系:IAB在接受心脏手术的患者中发病率较高。IAB的存在与术后房颤的发生有明显的关联。我们的研究结果首次证实,IAB 对预测心脏手术后房颤的发生具有很高的特异性、敏感性和阴性预测价值。
{"title":"Role of the Presence of Interatrial Block as a Prediction Pathway of Atrial Fibrillation During the Postoperative Period of Patients Undergoing Cardiac Surgery.","authors":"Alfredo J Meza-Delgado, Osmar Antonio Centurión, Christian O Chavez-Alfonso, Rocío Del Pilar Falcón-Fleytas, Laura B García-Bello, Orlando R Sequeira-Villar, Carmen R Montiel-Gómez, José C Candia-Irala, Erdulfo J Galeano","doi":"10.1097/HPC.0000000000000384","DOIUrl":"10.1097/HPC.0000000000000384","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is the most frequently recorded arrhythmia in clinical practice, and its appearance conditions high risk of morbidity and mortality. The role of the interatrial block (IAB) as a predictor pathway of the development of AF in the postoperative period of patients undergoing cardiac surgery has been studied scantly.</p><p><strong>Methods: </strong>Partial IAB was defined as the P wave >120 ms and advanced IAB as the P wave >120 ms with biphasic morphology in inferior leads. The presurgical electrocardiography was analyzed, and the frequency of AF onset in the postoperative period was determined. A comparative analysis was performed between the patients who presented AF and those who did not.</p><p><strong>Results: </strong>A total of 94 patients were included, with a mean age of 61 ± 16 years. Of the total number of patients, 42 (45%) presented some degree of IAB (partial 42.8% and advanced 57.1%). There was a significant relationship between patients with IAB and those who developed AF postcardiac surgery (21.3%; P < 0.01). The presence of IAB had an area under the curve of 0.75 (95% confidence interval, 0.66-0.85) and demonstrated a specificity of 69%, a sensitivity of 83%, and a negative predictive value of 92% for predicting AF development.</p><p><strong>Conclusions: </strong>IAB has a relatively frequent incidence in patients undergoing cardiac surgery. There was a significant association between the presence of IAB and the development of AF in the postoperative period. Our findings establish for the first time that IAB has high specificity, sensitivity, and negative predictive value for predicting AF development postcardiac surgery.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0384"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Access to Nonphysician Led Exercise Stress Echocardiography Reduces Wait Times and Improves Consumer Engagement. 非医生引导的运动压力超声心动图减少了等待时间,提高了消费者的参与度。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000379
Mark Whitman, Carly Jenkins, Prasad Challa

The performance of nonphysician-led exercise stress testing with and without echocardiography has shown similar diagnostic utility and safety as physician-led models. While diagnostic accuracy and relative safety have been the focus of previous research, the current study aims to demonstrate efficiencies not previously reported, such as reduction in wait times for testing and improved service attendance. A nonphysician-led exercise stress echocardiography service was implemented on January 01, 2018; before this, all tests were performed under a physician-led model. Retrospective data was retrieved from both models (physician-led model from January 01, 2015 to December 31, 2017 and the nonphysician-led model from January 01, 2018 to December 31, 2023). Comparisons were made between the models regarding the number of tests performed, the average wait time to access testing, and the did not attend (DNA) rates. On average, 212 tests were performed in the physician-led model per year, with average wait times to access testing of 11.3 weeks and a DNA rate of 15.3%. In contrast, the nonphysician-led model performed on average 501 tests per year (135% increase) ( P < 0.001) with average wait times of 6 weeks (47% decrease) ( P < 0.01) and DNA rate of 4.8% (69% decrease). Despite the physician-led group displaying an overall higher cardiovascular disease risk, there were no adverse cardiovascular events at the time of testing in either model. Nonphysician-led exercise stress echocardiography remains as safe as physician-led models but demonstrates service improvements, including significant reductions in wait times and lower DNA rates.

有和没有超声心动图的非医生领导的运动压力测试显示出与医生领导的模型相似的诊断效用和安全性。虽然诊断的准确性和相对安全性一直是先前研究的重点,但目前的研究旨在证明以前未报道的效率,例如减少等待检测的时间和提高服务出勤率。非医生主导的运动应激超声心动图(ESE)服务于2018年1月1日实施,在此之前,所有测试都是在医生主导的模式下进行的。从两个模型中检索回顾性数据(2015年1月1日至2017年12月31日由医生领导的模型和2018年1月1日至2023年12月31日由非医生领导的模型)。在模型之间进行了关于执行的测试次数、获得测试的平均等待时间和未参加(DNA)率的比较。在医生主导的模式下,每年平均进行212次检测,平均等待时间为11.3周,DNA率为15.3%。相比之下,非医生主导的模型平均每年进行501次测试(增加135%)
{"title":"Access to Nonphysician Led Exercise Stress Echocardiography Reduces Wait Times and Improves Consumer Engagement.","authors":"Mark Whitman, Carly Jenkins, Prasad Challa","doi":"10.1097/HPC.0000000000000379","DOIUrl":"10.1097/HPC.0000000000000379","url":null,"abstract":"<p><p>The performance of nonphysician-led exercise stress testing with and without echocardiography has shown similar diagnostic utility and safety as physician-led models. While diagnostic accuracy and relative safety have been the focus of previous research, the current study aims to demonstrate efficiencies not previously reported, such as reduction in wait times for testing and improved service attendance. A nonphysician-led exercise stress echocardiography service was implemented on January 01, 2018; before this, all tests were performed under a physician-led model. Retrospective data was retrieved from both models (physician-led model from January 01, 2015 to December 31, 2017 and the nonphysician-led model from January 01, 2018 to December 31, 2023). Comparisons were made between the models regarding the number of tests performed, the average wait time to access testing, and the did not attend (DNA) rates. On average, 212 tests were performed in the physician-led model per year, with average wait times to access testing of 11.3 weeks and a DNA rate of 15.3%. In contrast, the nonphysician-led model performed on average 501 tests per year (135% increase) ( P < 0.001) with average wait times of 6 weeks (47% decrease) ( P < 0.01) and DNA rate of 4.8% (69% decrease). Despite the physician-led group displaying an overall higher cardiovascular disease risk, there were no adverse cardiovascular events at the time of testing in either model. Nonphysician-led exercise stress echocardiography remains as safe as physician-led models but demonstrates service improvements, including significant reductions in wait times and lower DNA rates.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0379"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal Trends and Outcomes of Peripheral Artery Disease and Critical Limb Ischemia in the United States. 美国外周动脉疾病和严重肢体缺血的时间趋势和结果。
Q3 Medicine Pub Date : 2025-06-01 Epub Date: 2025-05-23 DOI: 10.1097/HPC.0000000000000377
Chayakrit Krittanawong, Kimberly Imoh, Song Peng Ang, Yusuf Kamran Qadeer, Hafeez Ul Hassan Virk, Mahboob Alam, Carl J Lavie, Raman Sharma

Introduction: Peripheral artery disease (PAD) is a progressive, systemic atherosclerotic disease that is associated with an increased risk of coronary artery disease, cerebrovascular disease, and critical limb ischemia (CLI). CLI represents the most severe stage of PAD, characterized by progressive endothelial dysfunction and arterial narrowing. We hypothesized that the incidence of CLI and PAD would increase over the study period and that the rates of in-hospital mortality and major amputations among patients admitted with CLI would rise correspondingly.

Methods: We utilized the National Inpatient Sample database from 2016 to 2021 using the International Classification of Disease, Tenth Edition, Clinical Modification codes. Patients with primary or secondary diagnoses of PAD were initially selected, and subsequently hospitalization with CLI was appropriately identified. The Cochran Armitage test was used to describe the trend of outcomes across the years. All statistical analyses were conducted using the software Stata version 17.0.

Results: From 2016 to 2021, there were 2,930,639 admissions for CLI. Up to 65% of these patients were over the age of 60, and 35.8% of these patients were women. Most of these individuals were white (64.7%), followed by African Americans (15.8%) and Hispanics (12.6%). In-hospital mortality rates varied by revascularization method, with hybrid revascularization showing the highest rate at 2.6%, followed by endovascular revascularization at 1.8%, and surgical revascularization at 1.6%. Additionally, hospitalization costs were highest for patients undergoing hybrid revascularization ($46,257 ± $36,417), compared with endovascular ($36,924 ± $27,945) and surgical revascularization ($35,672 ± $27,127). Endovascular revascularization rates seemed to increase while surgical revascularization rates decreased during this time period.

Conclusions: PAD is a progressive, systemic atherosclerotic disease that is associated with an increased risk of coronary artery disease, cerebrovascular disease, and CLI. Our data showed that the rates of PAD and CLI hospitalizations have remained relatively stable from 2016 to 2021, but there seems to be a trend toward doing more revascularization via an endovascular approach as compared to a surgical approach.

简介:外周动脉疾病(PAD)是一种进行性、全身性动脉粥样硬化疾病,与冠状动脉疾病(CAD)、脑血管疾病(CVD)和严重肢体缺血(CLI)的风险增加有关。临界肢体缺血是 PAD 最严重的阶段,其特点是进行性内皮功能障碍和动脉狭窄。我们假设,在研究期间,CLI 和 PAD 的发病率会增加,CLI 患者的院内死亡率和主要截肢率也会相应增加:我们利用 2016 年至 2021 年的全国住院患者抽样(NIS)数据库,使用 ICD-10-CM 编码。我们首先选择了主要或次要诊断为 PAD 的患者,然后对 CLI 住院患者进行了适当识别。Cochran Armitage 检验用于描述不同年份的结果趋势。所有统计分析均使用Stata 17.0版软件进行:2016-2021年,共有2,930,639人因严重肢体缺血入院治疗。其中 65% 的患者年龄在 60 岁以上,35.8% 的患者为女性。其中大部分是白人(64.7%),其次是非裔美国人(15.8%)和西班牙裔美国人(12.6%)。院内死亡率因血管再通方法而异,其中混合血管再通的死亡率最高,为 2.6%,其次是血管内再通术,为 1.8%,手术血管再通术为 1.6%。此外,接受杂交血管再造术的患者住院费用最高(46257美元±36417美元),而接受血管内再造术(36924美元±27945美元)和外科再造术(35672美元±27127美元)的患者住院费用最低。在此期间,血管内再通率似乎有所上升,而手术再通率则有所下降:结论:PAD 是一种进行性、全身性动脉粥样硬化疾病,与 CAD、CVD 和 CLI 风险增加有关。我们的数据显示,PAD 和 CLI 住院率在 2016-2021 年间保持相对稳定,但与手术方法相比,似乎有通过血管内方法进行血管重建的趋势。
{"title":"Temporal Trends and Outcomes of Peripheral Artery Disease and Critical Limb Ischemia in the United States.","authors":"Chayakrit Krittanawong, Kimberly Imoh, Song Peng Ang, Yusuf Kamran Qadeer, Hafeez Ul Hassan Virk, Mahboob Alam, Carl J Lavie, Raman Sharma","doi":"10.1097/HPC.0000000000000377","DOIUrl":"10.1097/HPC.0000000000000377","url":null,"abstract":"<p><strong>Introduction: </strong>Peripheral artery disease (PAD) is a progressive, systemic atherosclerotic disease that is associated with an increased risk of coronary artery disease, cerebrovascular disease, and critical limb ischemia (CLI). CLI represents the most severe stage of PAD, characterized by progressive endothelial dysfunction and arterial narrowing. We hypothesized that the incidence of CLI and PAD would increase over the study period and that the rates of in-hospital mortality and major amputations among patients admitted with CLI would rise correspondingly.</p><p><strong>Methods: </strong>We utilized the National Inpatient Sample database from 2016 to 2021 using the International Classification of Disease, Tenth Edition, Clinical Modification codes. Patients with primary or secondary diagnoses of PAD were initially selected, and subsequently hospitalization with CLI was appropriately identified. The Cochran Armitage test was used to describe the trend of outcomes across the years. All statistical analyses were conducted using the software Stata version 17.0.</p><p><strong>Results: </strong>From 2016 to 2021, there were 2,930,639 admissions for CLI. Up to 65% of these patients were over the age of 60, and 35.8% of these patients were women. Most of these individuals were white (64.7%), followed by African Americans (15.8%) and Hispanics (12.6%). In-hospital mortality rates varied by revascularization method, with hybrid revascularization showing the highest rate at 2.6%, followed by endovascular revascularization at 1.8%, and surgical revascularization at 1.6%. Additionally, hospitalization costs were highest for patients undergoing hybrid revascularization ($46,257 ± $36,417), compared with endovascular ($36,924 ± $27,945) and surgical revascularization ($35,672 ± $27,127). Endovascular revascularization rates seemed to increase while surgical revascularization rates decreased during this time period.</p><p><strong>Conclusions: </strong>PAD is a progressive, systemic atherosclerotic disease that is associated with an increased risk of coronary artery disease, cerebrovascular disease, and CLI. Our data showed that the rates of PAD and CLI hospitalizations have remained relatively stable from 2016 to 2021, but there seems to be a trend toward doing more revascularization via an endovascular approach as compared to a surgical approach.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":"e0377"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Critical Pathways in Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1